首页 › 基金 › RA CAPITAL MANAGEMENT, L.P. › COAG
RA CAPITAL MANAGEMENT, L.P. 对 COAG 的持仓历史
HEMAB THERAPEUTICS HLDGS INC · 医疗保健
RA CAPITAL MANAGEMENT, L.P. 在 Q3 2026 的 13F 申报中披露持有 COAG(HEMAB THERAPEUTICS HLDGS INC)7,808,627 股,市值约 US$240.8M,约占其申报组合的 2.48%,在其申报持仓中市值排名第 7 位。 RA CAPITAL MANAGEMENT, L.P. 最近 2 个申报季度中有 2 个季度披露了 COAG 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
RA CAPITAL MANAGEMENT, L.P. 对 COAG 的持仓演变
RA CAPITAL MANAGEMENT, L.P. 于 Q2 2026 首次披露 COAG 持仓:7,808,627 股(约 US$286.8M)。 在 2 次申报中,RA CAPITAL MANAGEMENT, L.P. 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 7,808,627 股、市值约 US$240.8M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 7.81M | $286.81M | 新进 |
| Q3 2026 | 7.81M | $240.82M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 COAG 与 13F 数据
COAG(HEMAB THERAPEUTICS HLDGS INC)属于医疗保健行业。我们追踪的基金中还有 90 只申报持有 COAG,申报仓位最大的包括:Novo Holdings A/S (US$128.9M), Deep Track Capital, LP (US$110.6M), Siren, L.L.C. (US$73.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 COAG 的基金
- Novo Holdings A/S 4.18M 股 · $128.93M · Q3 2026
- Deep Track Capital, LP 3.59M 股 · $110.65M · Q3 2026
- Siren, L.L.C. 2.37M 股 · $72.97M · Q3 2026
- Avoro Capital Advisors LLC 1.89M 股 · $58.36M · Q3 2026
- Bain Capital Life Sciences Investors, LLC 1.65M 股 · $50.89M · Q3 2026
- Paradigm Biocapital Advisors LP 629.35K 股 · $19.41M · Q3 2026
- Rock Springs Capital Management LP 575.43K 股 · $17.75M · Q3 2026
- Affinity Asset Advisors, LLC 420.00K 股 · $12.95M · Q3 2026
- Parkman Healthcare Partners LLC 329.25K 股 · $10.15M · Q3 2026
- Opaleye Management Inc. 47.65K 股 · $1.75M · Q2 2026
更多关于 RA CAPITAL MANAGEMENT, L.P.
常见问题
How long has RA CAPITAL MANAGEMENT, L.P. held COAG?
RA CAPITAL MANAGEMENT, L.P. has disclosed COAG holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is RA CAPITAL MANAGEMENT, L.P.'s current position in COAG?
As of Q3 2026, RA CAPITAL MANAGEMENT, L.P. holds 7.81M shares of COAG (HEMAB THERAPEUTICS HLDGS INC), valued at $240.82M, representing 2.48% of its reported portfolio and ranking #7.
Has RA CAPITAL MANAGEMENT, L.P. been buying or selling COAG?
In the latest 13F filing (Q3 2026), RA CAPITAL MANAGEMENT, L.P. held unchanged its position in COAG.
Which other funds hold COAG?
Other major institutional holders of COAG include Novo Holdings A/S, Deep Track Capital, LP, Siren, L.L.C., among 90 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.